These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9354177)

  • 1. Correspondence of salivary and plasma concentrations of atrazine in rats under variable salivary flow rate and plasma concentration.
    Lu C; Anderson LC; Morgan MS; Fenske RA
    J Toxicol Environ Health; 1997 Nov; 52(4):317-29. PubMed ID: 9354177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of atrazine levels in whole saliva and plasma in rats: potential of salivary monitoring for occupational exposure.
    Lu C; Anderson LC; Fenske RA
    J Toxicol Environ Health; 1997 Feb; 50(2):101-11. PubMed ID: 9048955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary concentrations of atrazine reflect free atrazine plasma levels in rats.
    Lu C; Anderson LC; Morgan MS; Fenske RA
    J Toxicol Environ Health A; 1998 Feb; 53(4):283-92. PubMed ID: 9490326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological monitoring of diazinon exposure using saliva in an animal model.
    Lu C; Irish RM; Fenske R
    J Toxicol Environ Health A; 2003 Dec; 66(24):2315-25. PubMed ID: 14630523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physiologically based pharmacokinetic model for atrazine and its main metabolites in the adult male C57BL/6 mouse.
    Lin Z; Fisher JW; Ross MK; Filipov NM
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):16-31. PubMed ID: 21094656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic modeling of disposition and time-course studies with [14C]atrazine.
    McMullin TS; Brzezicki JM; Cranmer BK; Tessari JD; Andersen ME
    J Toxicol Environ Health A; 2003 May; 66(10):941-64. PubMed ID: 12825238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the chlorpyrifos metabolite 3,5,6-trichloro-2-pyridinol (TCPy) in rat saliva.
    Smith JN; Wang J; Lin Y; Timchalk C
    Toxicol Sci; 2010 Feb; 113(2):315-25. PubMed ID: 19920072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed-effect models for evaluating multiple measures of atrazine exposure among custom applicators.
    Hines CJ; Deddens JA; Lu C; Fenske R; Striley CA
    J Occup Environ Hyg; 2006 May; 3(5):274-83. PubMed ID: 16595379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disopyramide concentrations in saliva.
    Aitio ML; Virtanen R; Lammintausta R
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saliva biomonitoring of atrazine exposure among herbicide applicators.
    Denovan LA; Lu C; Hines CJ; Fenske RA
    Int Arch Occup Environ Health; 2000 Sep; 73(7):457-62. PubMed ID: 11057414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of lead (Pb) in saliva and blood of Sprague-Dawley rats following a single or repeated oral exposure to Pb-acetate.
    Timchalk C; Lin Y; Weitz KK; Wu H; Gies RA; Moore DA; Yantasee W
    Toxicology; 2006 May; 222(1-2):86-94. PubMed ID: 16510233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependency of salivary excretion of mexiletine on the plasma concentration in rats.
    Nagasako S; Iwamoto K; Hayashibara M; Katagiri Y
    J Pharm Pharmacol; 1993 Feb; 45(2):154-6. PubMed ID: 8095536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of prolonged gum chewing on salivary flow rate and composition.
    Dawes C; Kubieniec K
    Arch Oral Biol; 2004 Aug; 49(8):665-9. PubMed ID: 15196984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of acetaminophen P-glycoprotein-mediated salivary secretion by rat submandibular glands.
    Schaiquevich P; Viviana N; Omar T; Modesto R
    Arch Oral Biol; 2004 Nov; 49(11):895-901. PubMed ID: 15353245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of 14C-atrazine following an acute lactational exposure in the Wistar rat.
    Stoker TE; Cooper RL
    Reprod Toxicol; 2007 Jun; 23(4):607-10. PubMed ID: 17399945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between unstimulated salivary flow rate and saliva composition of healthy children in Taiwan.
    Wu KP; Ke JY; Chung CY; Chen CL; Hwang TL; Chou MY; Wong AM; Hu CF; Lee YC
    Chang Gung Med J; 2008; 31(3):281-6. PubMed ID: 18782951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of saliva for drug monitoring. An in vivo model for transmembrane transport.
    Haeckel R; Hänecke P
    Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):171-91. PubMed ID: 8721405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence of salivary drug concentration on salivary flow rate.
    Wood JH; Flora KP; Narasimhachari N; Baker CA
    Methods Find Exp Clin Pharmacol; 1982; 4(4):255-60. PubMed ID: 7121134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary excretion of 5-fluorouracil (5-FU). IV. Dependency of saliva/plasma concentration ratio and salivary clearance on plasma concentration of 5-FU during constant-rate intravenous infusion in rats.
    Hayashi Y; Watanabe J; Ozeki S
    J Pharmacobiodyn; 1989 Mar; 12(3):137-44. PubMed ID: 2760793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation.
    Chambers MS; Tomsett KL; Artopoulou II; Garden AS; El-Naggar AK; Martin JW; Keene HJ
    J Prosthet Dent; 2008 Aug; 100(2):142-6. PubMed ID: 18672129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.